These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

259 related articles for article (PubMed ID: 26886763)

  • 1. Kinetics and Molecular Docking Study of an Anti-diabetic Drug Glimepiride as Acetylcholinesterase Inhibitor: Implication for Alzheimer's Disease-Diabetes Dual Therapy.
    Rizvi SM; Shaikh S; Naaz D; Shakil S; Ahmad A; Haneef M; Abuzenadah AM
    Neurochem Res; 2016 Jun; 41(6):1475-82. PubMed ID: 26886763
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Invokana (Canagliflozin) as a dual inhibitor of acetylcholinesterase and sodium glucose co-transporter 2: advancement in Alzheimer's disease- diabetes type 2 linkage via an enzoinformatics study.
    Rizvi SM; Shakil S; Biswas D; Shakil S; Shaikh S; Bagga P; Kamal MA
    CNS Neurol Disord Drug Targets; 2014 Apr; 13(3):447-51. PubMed ID: 24059302
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pyridine sulfonamide as a small key organic molecule for the potential treatment of type-II diabetes mellitus and Alzheimer's disease: In vitro studies against yeast α-glucosidase, acetylcholinesterase and butyrylcholinesterase.
    Riaz S; Khan IU; Bajda M; Ashraf M; Qurat-Ul-Ain ; Shaukat A; Rehman TU; Mutahir S; Hussain S; Mustafa G; Yar M
    Bioorg Chem; 2015 Dec; 63():64-71. PubMed ID: 26451651
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Forxiga (dapagliflozin): Plausible role in the treatment of diabetes-associated neurological disorders.
    Shaikh S; Rizvi SM; Shakil S; Riyaz S; Biswas D; Jahan R
    Biotechnol Appl Biochem; 2016; 63(1):145-50. PubMed ID: 25402624
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prediction of Anti-Diabetic Drugs as Dual Inhibitors Against Acetylcholinesterase and Beta-Secretase: A Neuroinformatics Study.
    Shaikh S; Rizvi SM; Suhail T; Shakil S; Abuzenadah AM; Anis R; Naaz D; Dallol A; Haneef M; Ahmad A; Choudhary L
    CNS Neurol Disord Drug Targets; 2016; 15(10):1216-1221. PubMed ID: 27697060
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Glimepiride attenuates Aβ production via suppressing BACE1 activity in cortical neurons.
    Liu F; Wang Y; Yan M; Zhang L; Pang T; Liao H
    Neurosci Lett; 2013 Dec; 557 Pt B():90-4. PubMed ID: 24184877
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacophore mapping-based virtual screening followed by molecular docking studies in search of potential acetylcholinesterase inhibitors as anti-Alzheimer's agents.
    Ambure P; Kar S; Roy K
    Biosystems; 2014 Feb; 116():10-20. PubMed ID: 24325852
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibitory activities of major anthraquinones and other constituents from Cassia obtusifolia against β-secretase and cholinesterases.
    Jung HA; Ali MY; Jung HJ; Jeong HO; Chung HY; Choi JS
    J Ethnopharmacol; 2016 Sep; 191():152-160. PubMed ID: 27321278
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Linarin improves the dyskinesia recovery in Alzheimer's disease zebrafish by inhibiting the acetylcholinesterase activity.
    Pan H; Zhang J; Wang Y; Cui K; Cao Y; Wang L; Wu Y
    Life Sci; 2019 Apr; 222():112-116. PubMed ID: 30802512
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification of molecular descriptors for design of novel Isoalloxazine derivatives as potential Acetylcholinesterase inhibitors against Alzheimer's disease.
    Gurung AB; Aguan K; Mitra S; Bhattacharjee A
    J Biomol Struct Dyn; 2017 Jun; 35(8):1729-1742. PubMed ID: 27410776
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Avarol derivatives as competitive AChE inhibitors, non hepatotoxic and neuroprotective agents for Alzheimer's disease.
    Tommonaro G; García-Font N; Vitale RM; Pejin B; Iodice C; Cañadas S; Marco-Contelles J; Oset-Gasque MJ
    Eur J Med Chem; 2016 Oct; 122():326-338. PubMed ID: 27376495
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Assessment of Anticholinergic and Antidiabetic Properties of Some Natural and Synthetic Molecules: An
    Çomaklı V; Aygül İ; Sağlamtaş R; Kuzu M; Demirdağ R; Akincioğlu H; Adem Ş; Gülçin İ
    Curr Comput Aided Drug Des; 2024; 20(5):441-451. PubMed ID: 37202895
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Combining in silico and in vitro approaches to evaluate the acetylcholinesterase inhibitory profile of some commercially available flavonoids in the management of Alzheimer's disease.
    Kuppusamy A; Arumugam M; George S
    Int J Biol Macromol; 2017 Feb; 95():199-203. PubMed ID: 27871793
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The exploration of novel Alzheimer's therapeutic agents from the pool of FDA approved medicines using drug repositioning, enzyme inhibition and kinetic mechanism approaches.
    Hassan M; Raza H; Abbasi MA; Moustafa AA; Seo SY
    Biomed Pharmacother; 2019 Jan; 109():2513-2526. PubMed ID: 30551512
    [TBL] [Abstract][Full Text] [Related]  

  • 15. 2-Furoic piperazide derivatives as promising drug candidates of type 2 diabetes and Alzheimer's diseases: In vitro and in silico studies.
    Abbasi MA; Hassan M; Ur-Rehman A; Siddiqui SZ; Hussain G; Shah SAA; Ashraf M; Shahid M; Seo SY
    Comput Biol Chem; 2018 Dec; 77():72-86. PubMed ID: 30245349
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In silico identification of AChE and PARP-1 dual-targeted inhibitors of Alzheimer's disease.
    Hu XM; Dong W; Cui ZW; Gao CZ; Yu ZJ; Yuan Q; Min ZL
    J Mol Model; 2018 Jun; 24(7):151. PubMed ID: 29869722
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interaction of metal chelators with different molecular forms of acetylcholinesterase and its significance in Alzheimer's disease treatment.
    Chitra L; Kumar CR; Basha HM; Ponne S; Boopathy R
    Proteins; 2013 Jul; 81(7):1179-91. PubMed ID: 23408593
    [TBL] [Abstract][Full Text] [Related]  

  • 18. BACE1 molecular docking and anti-Alzheimer's disease activities of ginsenosides.
    Choi RJ; Roy A; Jung HJ; Ali MY; Min BS; Park CH; Yokozawa T; Fan TP; Choi JS; Jung HA
    J Ethnopharmacol; 2016 Aug; 190():219-30. PubMed ID: 27275774
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Design, synthesis, and evaluation of hydrazones as dual inhibitors of ryanodine receptors and acetylcholinesterases for Alzheimer's disease.
    Yang F; Zhao J; Chen G; Han H; Hu S; Wang N; Wang J; Chen Y; Zhou Z; Dai B; Hou Y; Liu Y
    Bioorg Chem; 2023 Apr; 133():106432. PubMed ID: 36841050
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Combined 3D-QSAR, molecular docking, and molecular dynamics study of tacrine derivatives as potential acetylcholinesterase (AChE) inhibitors of Alzheimer's disease.
    Zhou A; Hu J; Wang L; Zhong G; Pan J; Wu Z; Hui A
    J Mol Model; 2015 Oct; 21(10):277. PubMed ID: 26438408
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.